Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats
Hariom Kumar, Bhupesh Sharma
Brain Research Bulletin (2016) Vol. 124, pp. 27-39
Closed Access | Times Cited: 77

Showing 26-50 of 77 citing articles:

Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Autism Research (2021) Vol. 14, Iss. 11, pp. 2270-2286
Closed Access | Times Cited: 31
Potential crosstalk between sonic hedgehog‐WNT signaling and neurovascular molecules: Implications for blood–brain barrier integrity in autism spectrum disorder
Evelyne Gozal, Rekha Jagadapillai, Jun Cai, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 1, pp. 15-28
Open Access | Times Cited: 29
Memantine, an NMDA receptor antagonist, protected the brain against the long-term consequences of sepsis in mice
Zahra Bardaghi, Arezoo Rajabian, Farimah Beheshti, et al.
Life Sciences (2023) Vol. 323, pp. 121695-121695
Closed Access | Times Cited: 12
Animal models for autism in 2017 and the consequential implications to drug discovery
Kathryn K. Chadman
Expert Opinion on Drug Discovery (2017) Vol. 12, Iss. 12, pp. 1187-1194
Closed Access | Times Cited: 35
Deletion of Semaphorin 3F in Interneurons Is Associated with Decreased GABAergic Neurons, Autism-like Behavior, and Increased Oxidative Stress Cascades
Zhu Li, Rekha Jagadapillai, Evelyne Gozal, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5520-5538
Open Access | Times Cited: 32
Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism
Mauro Mozael Hirsch, Iohanna Deckmann, Júlio Santos‐Terra, et al.
Neuropharmacology (2020) Vol. 167, pp. 107930-107930
Open Access | Times Cited: 31
Looking for “fNIRS Signature” in Autism Spectrum: A Systematic Review Starting From Preschoolers
Eugenia Conti, Elena Scaffei, Chiara Bosetti, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 16
Memantine inhibits cortical spreading depolarization and improves neurovascular function following repetitive traumatic brain injury
Mark A. MacLean, Jamil H. Muradov, Ryan Greene, et al.
Science Advances (2023) Vol. 9, Iss. 50
Open Access | Times Cited: 10
Neurovascular crosstalk and cerebrovascular alterations: an underestimated therapeutic target in autism spectrum disorders
Yiran Wang, Shunyu Yu, Mengqian Li
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9
N-Methyl-D-Aspartate (NMDA) Receptor Antagonists and Their Pharmacological Implication: A Medicinal Chemistry-Oriented Perspective Outline
Vikas Rana, Shayantan Ghosh, Akanksha Bhatt, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 29, pp. 4725-4744
Closed Access | Times Cited: 3
Cerebrolysin prevents deficits in social behavior, repetitive conduct, and synaptic inhibition in a rat model of autism
Roberto Cuevas‐Olguin, Swagata Roychowdhury, Anwesha Banerjee, et al.
Journal of Neuroscience Research (2017) Vol. 95, Iss. 12, pp. 2456-2468
Closed Access | Times Cited: 31
Naringenin and its nanocarriers as potential phytotherapy for autism spectrum disorders
Ranjana Bhandari, Jyoti Paliwal, Anurag Kuhad
Journal of Functional Foods (2018) Vol. 47, pp. 361-375
Closed Access | Times Cited: 28
Dietary Approaches to the Management of Autism Spectrum Disorders
Richard E. Hartman, Dhira Patel
Advances in neurobiology (2020), pp. 547-571
Closed Access | Times Cited: 26
Resveratrol prevents brain edema, blood–brain barrier permeability, and altered aquaporin profile in autism animal model
Iohanna Deckmann, Júlio Santos‐Terra, Mellanie Fontes‐Dutra, et al.
International Journal of Developmental Neuroscience (2021) Vol. 81, Iss. 7, pp. 579-604
Open Access | Times Cited: 22
Novel potential of metformin on valproic acid‐induced autism spectrum disorder in rats: involvement of antioxidant defence system
Ismail O. Ishola, Aishat Oyinkansola Balogun, Olufunmilayo O. Adeyemi
Fundamental and Clinical Pharmacology (2020) Vol. 34, Iss. 6, pp. 650-661
Closed Access | Times Cited: 23
Inhibition of the ERK1/2 Phosphorylation by Dextromethorphan Protects against Core Autistic Symptoms in VPA Induced Autistic Rats: In Silico and in Vivo Drug Repurposition Study
Rubal Singla, Abhishek Mishra, Rupa Joshi, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 10, pp. 1749-1767
Closed Access | Times Cited: 18
Potential Cross Talk between Autism Risk Genes and Neurovascular Molecules: A Pilot Study on Impact of Blood Brain Barrier Integrity
Rekha Jagadapillai, Xiaolu Qiu, Kshama Ojha, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2211-2211
Open Access | Times Cited: 13
A snapshot on introspection of autism spectrum disorder
Govind Kale, Veeranjaneyulu Addepalli, Sharvari Joshi
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism
Eman A. E. Farrag, Mona H. Askar, Zienab Abdallah, et al.
Behavioral and Brain Functions (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist
Cristina Cosi, Jean‐Claude Martel, Agnès L. Auclair, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173635-173635
Closed Access | Times Cited: 20
Under or Absent Reporting of Light Stimuli in Testing of Anxiety-Like Behaviors in Rodents: The Need for Standardization
Lorenz S. Neuwirth, Michael T. Verrengia, Zachary I. Harikinish-Murrary, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 11
Prenatal exposure to valproic acid is associated with altered neurocognitive function and neurogenesis in the dentate gyrus of male offspring rats
Tomoya Kinjo, Masanobu Ito, Tatsunori Seki, et al.
Brain Research (2019) Vol. 1723, pp. 146403-146403
Closed Access | Times Cited: 19
Psychotropic and neurological medication effects on mitochondrial complex I and IV in rodent models
Lisa Holper, Dorit Ben‐Shachar, J. John Mann
European Neuropsychopharmacology (2019) Vol. 29, Iss. 9, pp. 986-1002
Closed Access | Times Cited: 16
Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Journal of Pharmacy and Pharmacology (2021) Vol. 73, Iss. 11, pp. 1460-1469
Closed Access | Times Cited: 14
Effect of vitamin B6on brain damage in valproic acid induced toxicity
İsmet Burcu Türkyılmaz, Nilay Altaş, İnci Arısan, et al.
Journal of Biochemical and Molecular Toxicology (2021) Vol. 35, Iss. 9
Closed Access | Times Cited: 12

Scroll to top